Q901: The Promising New Hope for Pediatric Brain Tumors - What You Need to Know About This FDA-Approved Therapy
AI 요약 정보
- Qurient gets FDA approval for Q901 pediatric cancer trial
- Trial targets children with recurrent medulloblastoma and AT/RT
- Q901 extended survival in preclinical pediatric tumor models
